New recommendations address GLP-1 medications across women's reproductive years

MedicalXpress | авг 04, 2026

As the use of GLP-1 and other incretin-based medications for obesity continues to grow worldwide, researchers at Marshall University have contributed to an international effort to address one of medicine's most pressing unanswered questions: How should these medications be used by women before, during and after pregnancy?